CSTL

Castle Biosciences Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Castle Biosciences Inc specializes in providing genetic diagnostic tests for skin cancers and other complex diseases.

$ 23.62
5.90 %

Castle Biosciences Inc

$ 23.62
5.90 %
CSTL

Castle Biosciences Inc specializes in providing genetic diagnostic tests for skin cancers and other complex diseases.

Price history of Castle Biosciences Inc
Price history of Castle Biosciences Inc

Performance & Momentum

6 Months 2.32 %
1 Year 11.05 %
3 Years 0.59 %
5 Years 65.05 %

Strategic Analysis

Castle Biosciences Inc • 2026

Castle Biosciences positions itself as a niche player in the healthcare sector, specializing in genetic diagnostic tests for skin cancers and complex diseases. Its model is based on biomedical innovation, aiming to improve risk stratification and personalized patient management.

Strengths
  • Deep expertise in oncological genetic diagnostics
  • Portfolio of clinically validated high-value tests
  • Rapid growth supported by the gradual adoption of tests in dermatology
Weaknesses
  • Significant dependence on a highly specialized market segment
  • History of long-term financial volatility
Momentum

The positive momentum reflects a renewed interest from investors linked to favorable business dynamics and the growing recognition of its solutions in the oncological field. This trend invites consideration of the stock from a selective growth perspective, while also accounting for risks related to regulatory and competitive developments.

Similar stocks to Castle Biosciences Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone